p53 Re-Activating Small Molecule Inhibitors for the Treatment of Pancreatic Cancer

QR Code

p53 Re-Activating Small Molecule Inhibitors for the Treatment of Pancreatic Cancer

None

Saved in:

Bibliographic Details
Main Authors:	Azmi, Asfar S., Choi, Minsig, Mohammad, Ramzi M.
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/33505
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Opto-p53: A light-controllable activation of p53 signaling pathway
by: Tatsuki Tsuruoka, et al.
Published: (2025-06-01)

The Functionality of p53 in Thyroid Cancer
by: Ray, Debolina, et al.
Published: (2012)

P53 Network in Ovarian Cancer
by: Moretti, Fabiola, et al.
Published: (2012)

The Interaction of DMRTA2 with HSP90β Inhibits p53 Ubiquitination and Activates the p53 Pathway to Suppress the Malignant Progression of Non-Small-Cell Lung Cancer
by: Shiyang Deng, et al.
Published: (2025-06-01)

Taurine Alleviates Pancreatic β‐Cell Senescence by Inhibition of p53 Pathway
by: Baomin Wang, et al.
Published: (2025-06-01)

Systems and Network Understanding of Cancer Stem Cells
by: Azmi, Asfar S., et al.
Published: (2011)

p53: Point Mutations, SNPs and Cancer
by: Fang, Ming, et al.
Published: (2012)

p53, p63 and p73 Network in Breast Cancers
by: Leong, Chee-Onn
Published: (2011)

The status of p53 affects the efficacy of PLK1 inhibitor BI6727 in prostate cancer cells
by: Wenjing Li, et al.
Published: (2025-07-01)

A Smart Nanoprobe for Visually Investigating the Activation Effect of Cyclical DOX Release on the p53 Pathway and Pathway-Related Molecules
by: Ping Sun, et al.
Published: (2025-06-01)

The Δ40p53 isoform inhibits p53-dependent eRNA transcription and enables regulation by signal-specific transcription factors during p53 activation.
by: Cecilia B Levandowski, et al.
Published: (2021-08-01)

Discovery of Drugs Targeting Mutant p53 and Progress in Nano-Enabled Therapeutic Strategy for p53-Mutated Cancers
by: Na Zhang, et al.
Published: (2025-05-01)

Review of Small Molecule Anticancer NF-κB Inhibitors
by: Sh. R. Kzyrgalin, et al.
Published: (2023-07-01)

New aspects of pharmacotherapy for rheumatoid arthritis: small molecule inhibitors
by: Evgeny Lvovich Nasonov, et al.
Published: (2012-04-01)

Small-molecule and peptide inhibitors of m6A regulators
by: Xiaocui Liu, et al.
Published: (2025-08-01)

Screening of small molecule inhibitors targeting DNA polymerase η
by: CAO Jiajia, et al.
Published: (2024-02-01)

α-Heteroarylthiomethyl ketones: Small molecule inhibitors of 3CLpro
by: Knez Damijan, et al.
Published: (2025-06-01)

APR-246 enhances the anticancer effect of doxorubicin against p53-mutant AsPC-1 pancreatic cancer cells
by: Ali Haider Alhammer, et al.
Published: (2024-08-01)

Rezatapopt: A promising small-molecule “refolder” specific for TP53Y220C mutant tumors
by: Kostas A. Papavassiliou, et al.
Published: (2025-09-01)

Structure-Based Design of Small-Molecule Inhibitors of Human Interleukin-6
by: Ankit Joshi, et al.
Published: (2025-07-01)

Semiconducting Small Molecules as Active Materials for p‐Type Accumulation Mode Organic Electrochemical Transistors
by: Zachary S. Parr, et al.
Published: (2020-06-01)

Design and experimental validation of the action of small molecule-based inhibitors of the FADD protein
by: N. V. Ivanisenko, et al.
Published: (2016-01-01)

Knockdown of p53 Enhances LncRNA A2M‐AS1 Inhibition of Pancreatic Cancer Progression via Regulating MAPK Pathway
by: Yu Cen, et al.
Published: (2025-07-01)

Δ133p53α and Δ160p53α isoforms of the tumor suppressor protein p53 exert dominant-negative effect primarily by co-aggregation
by: Liuqun Zhao, et al.
Published: (2025-07-01)

TP53-dependence on the effect of doxorubicin and Src inhibitor combination therapy
by: Yun Sun Lee, et al.
Published: (2018-08-01)

Identification of CNOT1-CCR4-NOT as a suppressor of 53BP1-p53-p21 signaling
by: Antonio Galarreta, et al.
Published: (2025-08-01)

p53 as a Therapeutic Target in T-ALL
by: Riz, Irene, et al.
Published: (2011)

Presence and Interactions of Entamoeba histolytica Lectin and p53 Protein in Colorectal Cancer
by: Leila Haghighi, et al.
Published: (2025-06-01)

Targeted protein degradation with small molecules for cancer immunotherapy
by: Zichao Yang, et al.
Published: (2025-08-01)

The prognostic value of p53 positive in colorectal cancer: A retrospective cohort study
by: Peng Wang, et al.
Published: (2017-04-01)

Ultra-rapid analysis of p53 gene for lung cancer diagnosis within 60 s
by: Yang Yu, et al.
Published: (2025-06-01)

Estimation of the state of proliferative activity and expression of the oncomarker p53 in samples of actinic keratosis.
by: V. S. Hlushok, et al.
Published: (2017-09-01)

Study of the expression of oncoprotein p53, EGFR in colorectal carcinomas with different proliferative activity
by: I.S. Shponka, et al.
Published: (2023-04-01)

p53 Mutation and Multiple Primary Oral Squamous Cell Carcinomas
by: Hassan, Nur Mohammad Monsur, et al.
Published: (2012)

RELATIONSHIP BETWEEN APOPTOSIS MARKERS(P53, BCL-2, BAX) AND CLINICAL-MORPHOLOGICAL PARAMETERS AND SURVIVAL IN NON-SMALL CELL LUNG CANCER
by: D. S. Kobyakov, et al.
Published: (2016-02-01)

HPLC of small molecules : a practical approach /
Published: (1986)

Evaluation of p53, p16INK4a and E-Cadherin Status as Biomarkers for Cervical Cancer Diagnosis
by: Mzibri, M. El, et al.
Published: (2012)

p16 gene silencing along with p53 single-nucleotide polymorphism and risk of esophageal cancer in Northeast India
by: Mandakini Das, et al.
Published: (2017-04-01)

Caspase-9 and p53 Protein Levels in Cancer Patients after Different Anesthesia Techniques
by: A. O. Soloviev, et al.
Published: (2024-12-01)

Small molecule inhibitor of tau self-association in a mouse model of tauopathy: A preventive study in P301L tau JNPL3 mice.
by: Eliot J Davidowitz, et al.
Published: (2023-01-01)